BackgroundCheck.run
Search For

Dong Bo Chen, 728 Stimson Ave, Lexington, MA 02421

Known as:
Dong B Chen Dongbo Chen Bob D Chen Bo B Chen Robert Chen Bo Chen Dongbo Bo Chen Dong
Related to:
Wan S Chen Yong C Cheng 57

Dong Chen Phones & Addresses

8 Stimson Ave, Lexington, MA 02421   

Keller, TX   

Las Vegas, NV   

Burlington, MA   

Boston, MA   

Medford, MA   

Woburn, MA   

Work

Company: Portland community college Address: 12000 Sw 49Th Ave, Boston, MA 02110 Phones: 617-9510770 Position: Lingfood Industries: Semiconductors and Related Devices
Get Report
Control this profile

Mentions for Dong Bo Chen

Career records & work history

Medicine Doctors

Dong Chen

Specialties:
Hematology, Anatomic Pathology & Clinical Pathology
Work:
Mayo Clinic Laboratory Medicine & Pathology
200 1 St Sw Hilton 8-15, Rochester, MN 55905
507-2842390 (phone) 507-2845115 (fax)
Education:
Medical School
Beijing Med Univ, Beijing City, Beijing, China
Graduated: 1992
Languages:
English, Spanish
Description:
Dr. Chen graduated from the Beijing Med Univ, Beijing City, Beijing, China in 1992. He works in Rochester, MN and specializes in Hematology and Anatomic Pathology & Clinical Pathology.

Dong Chen resumes & CV records

Resumes

Dong Chen Photo 42

Programming Manager

Work:

Programming Manager
Dong Chen Photo 43

Dong Chen

Dong Chen Photo 44

Dong Chen

Dong Chen Photo 45

Dong Mi Chen

Dong Chen Photo 46

Dong Chen

Dong Chen Photo 47

Dong Chen

Dong Chen Photo 48

Dong Chen

Dong Chen Photo 49

Dong Chen

Location:
United States

Publications & IP owners

Us Patents

Methods Of Controlling Axonal Growth

US Patent:
2002005, May 16, 2002
Filed:
Nov 1, 2001
Appl. No.:
10/035376
Inventors:
Gerald Schneider - Brookline MA, US
Dong Chen - Brookline MA, US
Sonal Jhaveri - Brookline MA, US
Assignee:
Massachusetts Institute of Technology
International Classification:
A61K038/00
A01N037/18
US Classification:
514/002000, 514/012000
Abstract:
Agents which modulate a bcl family member to control axonal growth and regeneration are described. These bcl modulating agents promote axonal growth and regeneration in the neural cells of a subject. Compositions for promoting axonal cell growth in a subject also are described. The compositions of the present invention include an effective amount of an agent which modulates a bcl family member and in a pharmaceutically acceptable carrier. Other described aspects include packaged drugs for treating a state characterized by diminished potential for axonal growth. The packaged compounds and agents also include instructions for using the agent to promote axonal growth in a subject.

Methods And Compositions For Stimulating Axon Regeneration And Preventing Neuronal Cell Degeneration

US Patent:
2003010, Jun 5, 2003
Filed:
Feb 8, 2002
Appl. No.:
10/072830
Inventors:
Dong Chen - Newton MA, US
Xizhong Huang - Framingham MA, US
Guang Chen - Potomac MD, US
Husseini Manji - Rockville MD, US
International Classification:
A61K033/00
A61K038/18
C12N005/08
US Classification:
424/093700, 424/722000, 514/012000, 435/368000
Abstract:
Agents which modulate a bcl family member to control axonal growth and regeneration are described. These bcl modulating agents promote axonal growth and regeneration in the neural cells of a subject. Compositions for promoting axonal cell growth in a subject also are described. The compositions of the present invention include an effective amount of an agent which modulates a bcl family member and in a pharmaceutically acceptable carrier. Other described aspects include packaged drugs for treating a state characterized by diminished potential for axonal growth. The packaged compounds and agents also include instructions for using the agent to promote axonal growth in a subject. An exemplary agent is lithium or a salt thereof.

Methods And Compositions For Promoting Axon Regeneration And Cell Replacement Therapy

US Patent:
2005015, Jul 14, 2005
Filed:
Jun 25, 2004
Appl. No.:
10/877066
Inventors:
Dong Chen - Newton MA, US
Masumi Takeda - Boston MA, US
Reiko Kinouchi - Hokkaido, JP
International Classification:
A61K033/00
A61K031/19
US Classification:
424722000, 514557000
Abstract:
Provided herein are methods and compositions for rendering a cellular environment permissive to axon regeneration and neural cell transplantation. Methods for stimulating axon regeneration in adult subjects are also disclosed. The methods may comprise contacting a tissue with an agent that prevents glial scar formation, such as by inhibiting reactive astroglial cells, and optionally an agent that increases bcl-2 protein levels in neural cells. Exemplary agents include astrotoxin for inhibiting reactive astroglial cells and lithium for increasing bcl-2 protein levels.

Methods Of Controlling Axonal Growth

US Patent:
2005020, Sep 22, 2005
Filed:
Sep 23, 2004
Appl. No.:
10/947994
Inventors:
Gerald Schneider - Brookline MA, US
Dong Chen - Chestnut Hill MA, US
Sonal Jhaveri - Brookline MA, US
Assignee:
MASSACHUSETTS INSTITUTE OF TECHNOLOGY - Cambridge MA
International Classification:
A61K048/00
A61K038/17
US Classification:
514012000, 514044000
Abstract:
Agents which modulate a bcl family member to control axonal growth and regeneration are described. These bcl modulating agents promote axonal growth and regeneration in the neural cells of a subject. Compositions for promoting axonal cell growth in a subject also are described. The compositions of the present invention include an effective amount of an agent which modulates a bcl family member and in a pharmaceutically acceptable carrier. Other described aspects include packaged drugs for treating a state characterized by diminished potential for axonal growth. The packaged compounds and agents also include instructions for using the agent to promote axonal growth in a subject.

Therapy For Glaucoma And Optic Neuropathy By Targeting Colony Stimulating Factors

US Patent:
2020039, Dec 24, 2020
Filed:
Mar 5, 2019
Appl. No.:
16/977783
Inventors:
- Boston MA, US
Dong Feng Chen - Newtonville MA, US
International Classification:
C07K 16/24
A61K 9/00
A61K 38/19
C07K 16/28
Abstract:
The invention provides compositions and methods for treating optic neuropathic disorders.

Therapies That Target Autoimmunity For Treating Glaucoma And Optic Neuropathy

US Patent:
2014014, May 29, 2014
Filed:
Feb 28, 2012
Appl. No.:
14/002036
Inventors:
Dong Feng Chen - Newtonville MA, US
Jianzhu Chen - Lexington MA, US
Huihui Chen - Hunan, CN
International Classification:
G01N 33/68
G01N 33/569
A61K 45/06
A61K 39/395
A61K 31/436
US Classification:
424 854, 4241731, 4241541, 514291, 435 792, 435 724
Abstract:
The present invention comprises a composition with means to inhibit an autoimmune response and methods for using this composition to treat glaucoma and optic neuropathy.

Compositions For Controlling Neuronal Outgrowth

US Patent:
2014012, May 8, 2014
Filed:
Feb 28, 2012
Appl. No.:
14/002033
Inventors:
Dong Feng Chen - Newtonville MA, US
Chenying Guo - Malden MA, US
International Classification:
A61K 31/708
A61K 45/06
A61K 31/7088
A61K 38/18
A61K 31/7004
US Classification:
514 89, 514 76, 514 86, 514 87, 514 23, 514 44 R, 514 45, 435375
Abstract:
Disclosed is a method of promoting neuronal growth by administering IGFBPL-1, or an agent that increases or stabilizes IGFBPL-1 activity to a subject in need thereof, e.g., a subject in need of treating optic nerve degeneration.

Possible Relatives

Cynthia Chen  David Chen  Cyril X Chen  Cyrus Y Chen  Dawei W Chen  De T Chen  Dafang Chen  Dong J Jun  Dong Jung  Dong Kang 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.